Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5001
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
$2.05B
| $1.13M | ﹤0.01% |
10,594
+6,848
| +183% | +$722K |
|
5002
Dimensional International Small Cap Value ETF
DISV
$4.88B
| $1.13M | ﹤0.01% |
29,636
-150
| -0.5% | -$5.44K |
|
5003
Douglas Elliman
DOUG
$160M
| $1.13M | ﹤0.01% |
474,882
+212,356
| +81% | +$546K |
|
|
FSSL
5004
FS Specialty Lending Fund
FSSL
$844M
| $1.12M | ﹤0.01% |
+79,470
| New | +$1.09M |
|
|
NXN
5005
DELISTED
Nuveen New York Tax-Free Income Portfolio
NXN
| $1.12M | ﹤0.01% |
92,885
+5,710
| +7% | +$69K |
|
|
AMBQ
5006
Ambiq Micro
AMBQ
$1.46B
| $1.12M | ﹤0.01% |
39,284
+30,573
| +351% | +$876K |
|
5007
E.W. Scripps
SSP
$282M
| $1.12M | ﹤0.01% |
280,457
-945,816
| -77% | -$3.18M |
|
|
CVGW
5008
DELISTED
Calavo Growers
CVGW
| $1.12M | ﹤0.01% |
51,321
-40,089
| -44% | -$889K |
|
5009
Immunic
IMUX
$182M
| $1.12M | ﹤0.01% |
209,101
-101,211
| -33% | -$741K |
|
5010
LCNB Corp
LCNB
$299M
| $1.11M | ﹤0.01% |
67,933
+12,738
| +23% | +$200K |
|
5011
StealthGas
GASS
$329M
| $1.11M | ﹤0.01% |
158,563
+17,690
| +13% | +$119K |
|
5012
Playboy Inc
PLBY
$141M
| $1.11M | ﹤0.01% |
592,051
-54,012
| -8% | -$88.2K |
|
5013
National CineMedia
NCMI
$371M
| $1.11M | ﹤0.01% |
286,067
-50,248
| -15% | -$208K |
|
|
CLPR
5014
Clipper Realty
CLPR
$46.5M
| $1.11M | ﹤0.01% |
291,288
-151,829
| -34% | -$567K |
|
5015
LifeMD
LFMD
$186M
| $1.11M | ﹤0.01% |
326,205
-649,552
| -67% | -$3.15M |
|
5016
Blue Ridge Bankshares
BRBS
$322M
| $1.11M | ﹤0.01% |
259,620
+41,769
| +19% | +$181K |
|
5017
1-800-Flowers.com
FLWS
$254M
| $1.11M | ﹤0.01% |
281,416
-447,909
| -61% | -$1.76M |
|
5018
International General Insurance
IGIC
$1.23B
| $1.1M | ﹤0.01% |
44,033
+1,362
| +3% | +$32K |
|
|
DOYU
5019
DouYu International Holdings
DOYU
$140M
| $1.1M | ﹤0.01% |
162,234
-55,292
| -25% | -$385K |
|
|
GLV
5020
Clough Global Dividend & Income Fund
GLV
$77.6M
| $1.1M | ﹤0.01% |
184,164
-6,723
| -4% | -$40.4K |
|
|
ATYR
5021
aTyr Pharma
ATYR
$48.4M
| $1.1M | ﹤0.01% |
1,403,009
+692,668
| +98% | +$568K |
|
|
TNGY
5022
Tortoise Energy ETF
TNGY
$535M
| $1.09M | ﹤0.01% |
120,216
+1,977
| +2% | +$18K |
|
|
DGXX
5023
Digi Power X Inc
DGXX
$332M
| $1.09M | ﹤0.01% |
425,535
+195,587
| +85% | +$733K |
|
5024
Zentalis Pharmaceuticals
ZNTL
$329M
| $1.08M | ﹤0.01% |
803,654
-604,175
| -43% | -$879K |
|
|
TBI
5025
Trueblue
TBI
$235M
| $1.08M | ﹤0.01% |
238,138
-13,729
| -5% | -$70.4K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.